Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

NCT04310020 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

47

Enrollment

NIH

Sponsor class

Conditions

Lung Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Stage III Lung Cancer AJCC v8

Interventions

DRUG: Atezolizumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
RADIATION: Hypofractionated Radiation Therapy
PROCEDURE: Magnetic Resonance Imaging

Sponsor

National Cancer Institute (NCI)